Register today and learn about:

Stable protein expression with the Gibco® Freedom® CHO-S® Kit

  • Easy-to-use, beginning-to-end product, for cloning and expression of recombinant proteins in Chinese Hamster Ovary (CHO)-derived suspension culture
  • Delivers high titers, and offers simplified commercial licensing options

 

Expi293TM Expression System - High-Density Mammalian Transient Protein Expression

A major advance in transient expression technology.

  • Rapid production of milligram to gram quantities of recombinant ultra high-yeild protein production in mammalian cells
  • High density cultures of Exi293TM cells that result in more expression cells per milliliter of culture and higher protein yeilds

 

GeneArt® Gene Synthesis

Your Serivce partner for gene synthesis through protein production. Outperform conventional techniques from time and economization to expression optimization, stability and quality.

  • GeneArt® Precision TALs
  • GeneArt® Gene Synthesis
  • GeneArt® Gene Optimizer® Technology
  • GeneArt® Directed Evolution

 

Vector NTI® Software

Completely intergrated suite of sequence analysis and designtools.

  • Help manage, view, analyze, transform, share, and publize diverse types of molecular biology data
  • All within one graphically rich analysis environment

Speakers

 

Dr Henry Chiou  (touring Australia only)

Senior Product Manager
Protein Expression, Life Technologies

Previously an R&D group leader for transfection, Henry directed the development of reagents such as Lipofectamine® LTX, Lipofectamine® RNAi. Now, as Senior Product Manager, Henry has led the development and launch of the new Expi293™ transient expression system. Prior to joining Life Technologies, Henry worked in small to mid-sized biotech companies on non-viral delivery systems for gene therapy.

 

Dr Shou Wong  (touring Australia and New Zealand)

Associate Director of Business Development
Synthetic Biology, Life Technologies

In 2000, Shou joined Novagen, as Group Leader for Mammalian Expression System. From 2000 to 2012, Shou worked at Merck KGaA where he held the position of Director of Technology Scouting making him responsible for identifying innovative early-stage platform technologies applicable to Pharmaceutical industry as well as Life Science and Chemical industries.

To register & join in your state, please complete and submit the form.

*
*
*
*